HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

valine-pyrrolidide

structure given in first source

Also Known As:

Val-pyrrolidide

Networked: 4 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrroles: 369
      - valine-pyrrolidide: 4
Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675
  - Branched-Chain Amino Acids: 2289
    - Valine: 1999
      - valine-pyrrolidide: 4
  - Essential Amino Acids: 1152
    - Valine: 1999
      - valine-pyrrolidide: 4

Experts

1.	Genade, S: 1 article (03/2008)
2.	Huisamen, B: 1 article (03/2008)
3.	Lochner, A: 1 article (03/2008)
4.	Bose, Amal K: 1 article (01/2005)
5.	Brand, Christian L: 1 article (01/2005)
6.	Carr, Richard D: 1 article (01/2005)
7.	Mocanu, Mihaela M: 1 article (01/2005)
8.	Yellon, Derek M: 1 article (01/2005)
9.	Inoue, Takashi: 1 article (08/2004)
10.	Kira, Kazunobu: 1 article (08/2004)

Related Diseases

1.	Infarction (Infarctions) 01/01/2005 - "In both studies, GLP-1 added before ischemia demonstrated a significant reduction in infarction compared with the valine pyrrolidide (an inhibitor of its breakdown) or saline groups. " 03/01/2008 - "In addition, GLP-1 had an infarct-sparing effect when supported by the presence of the dipeptidyl peptidase-IV inhibitor valine pyrrolidide. "
2.	Ischemia 01/01/2005 - "In both studies, GLP-1 added before ischemia demonstrated a significant reduction in infarction compared with the valine pyrrolidide (an inhibitor of its breakdown) or saline groups. "
3.	Glucose Intolerance 08/01/2004 - "In this study, we assessed the effects of subchronic treatment with metformin and a DPPIV inhibitor, valine-pyrrolidide (val-pyr), on glycemic control, food intake, and weight gain using Zucker fa/fa rats, a model of obesity and impaired glucose tolerance. "
4.	Weight Gain 08/01/2004 - "In this study, we assessed the effects of subchronic treatment with metformin and a DPPIV inhibitor, valine-pyrrolidide (val-pyr), on glycemic control, food intake, and weight gain using Zucker fa/fa rats, a model of obesity and impaired glucose tolerance. "
5.	Obesity 08/01/2004 - "In this study, we assessed the effects of subchronic treatment with metformin and a DPPIV inhibitor, valine-pyrrolidide (val-pyr), on glycemic control, food intake, and weight gain using Zucker fa/fa rats, a model of obesity and impaired glucose tolerance. "

Related Drugs and Biologics

1.	Glucagon-Like Peptide 1 (GLP 1)
2.	Metformin (Glucophage)
3.	Dipeptidyl-Peptidase IV Inhibitors
4.	Streptozocin (Streptozotocin)
5.	Niacinamide (Nicotinamide)
6.	Insulin (Novolin)

Related Therapies and Procedures

1.	Glycemic Control